Navigation Links
Arizona State University secures defense contract
Date:6/18/2012

TEMPE, Ariz. Arizona State University has been awarded a four-year contract from the Defense Threat Reduction Agency of the U.S. Department of Defense to develop a novel diagnostic technology called immunosignaturing for rapid detection of exposure to infectious disease agents before symptoms occur. This contract, with a cumulative value of $30,718,054, consists of a base period with 12 months of performance, valued at $9,057,732; and one option period with 36 months of performance, valued at $21,660,322.

Early detection saves lives by allowing rapid deployment of treatment and implementation of infection control measures to limit further spread, according to George Poste, chief scientist of the Complex Adaptive Systems Initiative at ASU.

Stephen Albert Johnston, co-director of the Center for Innovations in Medicine at ASU's Biodesign Institute, will lead the project. Johnston with co-principal investigators Poste and Neal Woodbury, co-director of the Center for Innovations in Medicine, will direct the effort to develop a silicon-chip based technology capable of detecting a broad range of infectious organisms based on their triggering the body to produce highly specific antibodies that are unique to each different infectious disease (the immunosignature).

Although this project seeks to develop a sophisticated and highly sensitive detection system to protect military personnel against bioterrorism, it is anticipated that immunosignature profiling will be equally valuable in creating a major advance in rapid detection of infectious and other disease in conventional medical settings.

Poste, a Regents' Professor and Del E. Webb Chair in Health Innovation, founded the Biodesign Institute at ASU before moving to establish the Complex Adaptive Systems Initiative, a research focus of the Office of Knowledge Enterprise Development.

Johnston is a professor in the ASU School of Life Sciences and with Woodbury co-directs the Center for Innovations in Medicine, which is bringing together the multidisciplinary scientific teams to develop the immunosignature diagnostic technology as well as a prophylactic cancer vaccine and new classes of therapeutics and anti-infectives.

Woodbury is a professor in ASU's Department of Chemistry and Biochemistry in the College of Liberal Arts and Sciences and a senior scientist in ASU's Global Institute of Sustainability. In addition to co-directing the Center for Innovations in Medicine, he leads research efforts to develop molecular devices and nanoscale hybrid electronics as miniaturized sensors for use in national security, medicine, environmental monitoring and remediation, and agriculture.

"Our success in securing this federal contract, one of the largest in ASU's history, is a compelling validation of the strength of our research faculty and our growing track record in innovation and technology," said Sethuraman "Panch" Panchanathan, senior vice president of Knowledge Enterprise Development.


'/>"/>
Contact: Carol Hughes
carol.hughes@asu.edu
480-965-6375
Arizona State University
Source:Eurekalert

Related medicine news :

1. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
2. Study reveals how cancer drug causes diabetic-like state
3. New drug prevents spread of human prostate cancer cells
4. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
5. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
6. Study examines adverse effects among different radiation therapies for prostate cancer
7. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
8. Warren Buffett Has Early Stage Prostate Cancer
9. Majority of states fail to address youth exposure to alcohol marketing
10. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
11. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... ... As recently as 2015, rhinoplasty was one of the Top 5 cosmetic ... patients want to make a change in the appearance of their nose while others ... team at usrhinoplasty.org is expanding its article database to better inform its ...
(Date:2/21/2017)... ... 2017 , ... American Veterinarian™, the premier multimedia provider of ... first bi-monthly issue of 2017 in February. The inaugural issue will offer expert ... , In making the announcement, American Veterinarian™ Publisher Chris Hennessy said, “We ...
(Date:2/21/2017)... San Francisco, California (PRWEB) , ... February 21, ... ... in the world with over 50,000 participants. The connected care demonstration spanned ... Office of the National Coordinator, roughly 30% of providers have no Health Information ...
(Date:2/21/2017)... ... February 21, 2017 , ... Along with Valentine’s Day, February marks ... small changes that can lead to a lifetime of heart health. In addition, ... emergency. , The Athletic Trainers’ Society of New Jersey (ATSNJ) is urging ...
(Date:2/20/2017)... ... 20, 2017 , ... Daily Body Restore, "DBR" a company ... “good” bacteria in the body, announced its Daily Body Restore® supplement is now ... Body Restore® is made with a unique combination of digestive enzymes and probiotics ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Mass Spectrometer Market: Overview ... This report on mass spectrometer ... prospects of the market globally. The stakeholders of ... the manufacture and commercialization of various mass spectrometer ... planning to enter this market. This report comprises ...
(Date:2/21/2017)... -- Luminex Corporation (NASDAQ: LMNX ) (the "Company") today ... of a quarterly cash dividend to its shareholders, the first ... payable on April 14, 2017 to shareholders of record as ... The board of directors intends for the Company ... holders of its common stock, representing a planned annual dividend ...
(Date:2/21/2017)... Feb. 21, 2017  Global health services company Cigna ... ® for breast reconstruction surgery and Dermacell ... an advanced acellular dermal matrix developed by LifeNet Health ... NVDQ ) "We are proud ... health-care payers to review the growing base of evidentiary ...
Breaking Medicine Technology: